Valuation (0%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | N/A | -17.48 |
| PEG Ratio (TTM) | N/A | -5.52 |
| P/S Ratio (TTM) | N/A | 38.76 |
| P/B Ratio (TTM) | N/A | 5.79 |
| P/FCF Ratio (TTM) | N/A | -147.98 |
| Price to 5YR AVG Earnings Ratio | N/A | -33.81 |
| Price to 5YR AVG FCF Ratio | N/A | -1.26 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | N/A | 286.55% |
| ROE (TTM) | N/A | -4,209.22% |
| Net Profit Margin (TTM) | N/A | -1,029.47% |
| ROIC 5YR AVG | N/A | -16.06% |
Growth (33%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -58,490.52% | 100,492.05% | N/A |
| Revenue | -45.72% | 22,533.57% | N/A |
| Net Income | -39,977.90% | 64,287.80% | N/A |
| Cash Flow | 468.83% | -220.34% | N/A |
Health (14%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | 4.93 |
| Quick Ratio (TTM) | N/A | 4.91 |
| D/E Ratio (TTM) | N/A | 1.28 |
| Interest Coverage (TTM) | N/A | -11.14 |
| Piotroski F-Score | 7 | 3 |
| Altman Z-Score | N/A | 20.90 |
| LTL to 5YR AVG FCF | N/A | -0.53 |
| Shares Outstanding Growth 5YR AVG | N/A | 887.86% |